ZA99874B - Organic compounds. - Google Patents
Organic compounds.Info
- Publication number
- ZA99874B ZA99874B ZA9900874A ZA99874A ZA99874B ZA 99874 B ZA99874 B ZA 99874B ZA 9900874 A ZA9900874 A ZA 9900874A ZA 99874 A ZA99874 A ZA 99874A ZA 99874 B ZA99874 B ZA 99874B
- Authority
- ZA
- South Africa
- Prior art keywords
- organic compounds
- epothilone
- administration
- methods
- pharmaceutical formulations
- Prior art date
Links
- 150000002894 organic compounds Chemical class 0.000 title 1
- 229930013356 epothilone Natural products 0.000 abstract 2
- 150000003883 epothilone derivatives Chemical class 0.000 abstract 2
- 239000012141 concentrate Substances 0.000 abstract 1
- 238000001802 infusion Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9802451.6A GB9802451D0 (en) | 1998-02-05 | 1998-02-05 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA99874B true ZA99874B (en) | 1999-08-05 |
Family
ID=10826504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9900874A ZA99874B (en) | 1998-02-05 | 1999-02-04 | Organic compounds. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1800664B8 (da) |
| AT (1) | ATE427736T1 (da) |
| CY (1) | CY1109190T1 (da) |
| DE (1) | DE69940708D1 (da) |
| DK (1) | DK1800664T3 (da) |
| ES (1) | ES2324376T3 (da) |
| GB (1) | GB9802451D0 (da) |
| PT (1) | PT1800664E (da) |
| ZA (1) | ZA99874B (da) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4138042C2 (de) * | 1991-11-19 | 1993-10-14 | Biotechnolog Forschung Gmbh | Epothilone, deren Herstellungsverfahren sowie diese Verbindungen enthaltende Mittel |
| JP4183099B2 (ja) * | 1995-11-17 | 2008-11-19 | ゲゼルシャフト・フュア・ビオテヒノロジッシェ・フォルシュング・ミット・ベシュレンクテル・ハフツング(ゲー・ベー・エフ) | エポチロンcおよびd、製造法ならびに組成物 |
| CN1304058C (zh) * | 1996-03-12 | 2007-03-14 | Pg-Txl有限公司 | 水溶性紫杉醇产品 |
| US6441186B1 (en) * | 1996-12-13 | 2002-08-27 | The Scripps Research Institute | Epothilone analogs |
| TR200002299T2 (tr) * | 1998-02-05 | 2000-11-21 | Novartis Ag | Epotilon kompozisyonları. |
-
1998
- 1998-02-05 GB GBGB9802451.6A patent/GB9802451D0/en not_active Ceased
-
1999
- 1999-02-03 DE DE69940708T patent/DE69940708D1/de not_active Expired - Lifetime
- 1999-02-03 PT PT07102856T patent/PT1800664E/pt unknown
- 1999-02-03 AT AT07102856T patent/ATE427736T1/de active
- 1999-02-03 EP EP07102856A patent/EP1800664B8/en not_active Revoked
- 1999-02-03 DK DK07102856T patent/DK1800664T3/da active
- 1999-02-03 ES ES07102856T patent/ES2324376T3/es not_active Expired - Lifetime
- 1999-02-04 ZA ZA9900874A patent/ZA99874B/xx unknown
-
2009
- 2009-06-30 CY CY20091100693T patent/CY1109190T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1109190T1 (el) | 2014-07-02 |
| ATE427736T1 (de) | 2009-04-15 |
| EP1800664B1 (en) | 2009-04-08 |
| DE69940708D1 (de) | 2009-05-20 |
| EP1800664B8 (en) | 2010-12-15 |
| GB9802451D0 (en) | 1998-04-01 |
| DK1800664T3 (da) | 2009-07-20 |
| ES2324376T3 (es) | 2009-08-05 |
| PT1800664E (pt) | 2009-07-10 |
| EP1800664A1 (en) | 2007-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY125921A (en) | Compositions containing organic compounds | |
| NZ513629A (en) | C-21 modified epothilones | |
| WO2000007979A3 (en) | Compounds and compositions for delivering active agents | |
| GEP20053473B (en) | High Potency Dihydroergotamine Compositions | |
| TW355683B (en) | Composition containing micronized nebivolol | |
| EP1093819A3 (en) | Compounds and compositions for delivering active agents | |
| IL231675A0 (en) | Concentrated protein compositions with reduced viscosity | |
| AU2001241423A1 (en) | Needleless syringe | |
| CA2338358A1 (en) | Compounds and compositions for delivering active agents | |
| AU2001237485A1 (en) | Needleless syringe with two injection speed levels | |
| GEP20043203B (en) | EP4 Receptor Selective Agonists in the Treatment of Osteoporosis | |
| IL136512A0 (en) | Intravenous infusion administration set | |
| WO2000040203A3 (en) | Polymeric delivery agents and delivery agent compounds | |
| NZ508249A (en) | Use of PEG-IFN-alpha conjugates in association with ribavirin for the treatment of chronic hepatitis C | |
| AU2002236647A1 (en) | Method and device for administering medication and/or placebo | |
| SI1121127T1 (en) | Oral pharmaceutical compositions containing buprenorphin | |
| EP1105102B8 (fr) | Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine | |
| WO2000003724A1 (en) | Preparations for immunotherapy for cancer having bacterial somatic constituent as the active ingredient | |
| AU1650501A (en) | 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient | |
| AU2001294240A1 (en) | 2,2-diphenylbutanamide derivatives and medicines containing the same | |
| GB9802451D0 (en) | Organic compounds | |
| IL154986A0 (en) | Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
| IL139863A0 (en) | 3,4-diphenyl bicyclo [4.3.0] nonyl derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same | |
| AU3076600A (en) | 3,7-disubstituted indole derivatives and medicinal compositions containing the same | |
| WO2001022917A8 (en) | Effervescent compositions comprising nimesulide |